---
schema_version: "secwatch.filing_event.v1"
accession: "0001380106-25-000195"
form_type: "8-K"
ticker: "RPID"
cik: "0001380106"
company_name: "RAPID MICRO BIOSYSTEMS, INC."
filed_at: "2025-11-07T23:59:59+00:00"
generated_at: "2026-05-16T22:59:57.940465+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Rapid Micro Biosystems Q3 revenue $7.8M (+3% YoY); raises FY guidance after record multi-system order

## Summary
- Q3 2025 revenue $7.8M (+3% YoY); recurring revenue up 32% to $4.8M on record consumables.
- Net loss $11.5M ($0.26 loss per share), flat YoY; gross margin improved to 9% from 8%.
- Receives largest multi-system order in company history from existing Top 20 global biopharma customer.
- Raises FY2025 revenue guidance to at least $33.0M, assumes at least 27 Growth Direct placements.
- Cash and equivalents $42M as of Sept 30, 2025.

## SEC filing metadata
- accession: 0001380106-25-000195
- form_type: 8-K
- ticker: RPID
- cik: 0001380106
- company_name: RAPID MICRO BIOSYSTEMS, INC.
- filed_at: 2025-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1380106/000138010625000195/0001380106-25-000195-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1380106/000138010625000195/rpid-20251107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001380106-25-000195
- JSON: https://secwatch.observer/filing/0001380106-25-000195.json
- Plain text: https://secwatch.observer/filing/0001380106-25-000195.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.